Brief: Nymox Provides Update On Regulatory Activities
29/03/2021 14:38
March 29 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX PROVIDES NEW UPDATE ON REGULATORY ACTIVITIES
* NYMOX PHARMACEUTICAL CORP - EXPECTS TO FILE FOR APPROVAL
FOR ITS
FIRST IN CLASS BPH TREATMENT FEXAPOTIDE TRIFLUTATE, DURING
SUMMER 2021
Source text for Eikon: ID:nGNX2Cxvgt
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba